HROW

MKT CAP:$1B

Harrow Health Inc

Market Cap

$1B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$33.19-$16.72 (-33.50%)

Jun 5, 2026

52W High $54.8052W Low $29.03

Company Details

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offer...

CEO

—

IPO Date

Sep 28, 2007

Website

www.harrow.com

Key Metrics TTM

Revenue

$269M

+26.2% YoY

Net Income

-$15M

EPS (Diluted)

Free Cash Flow

$14M

Revenue / Share

$7.22

Gross Margin

74.1%

Operating Margin

10.5%

Net Margin

-5.6%

FCF Margin

5.3%

P/S

4.7x

P/E

Earnings Reports

Q1 2026

May 11, 2026

$44M-7.6%

FY 2025

Mar 2, 2026

$272M+36.4%

Q4 2025

Mar 2, 2026

$89M+33.3%

Q3 2025

Nov 10, 2025

$72M+45.4%

Q2 2025

Aug 11, 2025

$64M+30.2%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee